These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 7372061)

  • 1. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
    Salen G; Verga D; Batta AK; Tint GS; Shefer S
    Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of ursodeoxycholic acid in man.
    Fedorowski T; Salen G; Calallilo A; Tint GS; Mosbach EH; Hall JC
    Gastroenterology; 1977 Nov; 73(5):1131-7. PubMed ID: 908492
    [No Abstract]   [Full Text] [Related]  

  • 6. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
    Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
    Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

  • 10. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-sulfated bile acids in rat liver cells. Studies on the toxicity of chenedeoxycholic acid].
    Kurtz W; Janka P; Swoboda L; Leuschner U
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():496-9. PubMed ID: 612015
    [No Abstract]   [Full Text] [Related]  

  • 12. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
    Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicity of chenodeoxycholic acid in the rhesus monkey.
    Dyrszka H; Chen T; Salen G; Mosbach EH
    Gastroenterology; 1975 Aug; 69(2):333-7. PubMed ID: 1150041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for ursodeoxycholic acid, and 7 oxo- and 12 oxo- bile acids.
    Haeffner LJ; Gordon SJ; Magen JS; Kowlessar OD
    J Lipid Res; 1980 May; 21(4):477-80. PubMed ID: 6929859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The content of cholylglycine in the blood serum in cholelithiasis during treatment with litholytic preparations of bile acids].
    Bocharova LV; Genia LP; Lemeshko ZA; Petrova EA
    Lab Delo; 1989; (3):59-61. PubMed ID: 2469846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.